A Busy Month for Physician Medical Group Deals

A Busy Month for Physician Medical Group Deals

December M&A activity hit over 200 deals, and we were struggling to remember a time when numbers hit that high, let alone in a historic pandemic (and more deals are expected to float to the surface in the next few weeks). Part of that surge in deal volume can be attributed to M&A in the Physician Medical Group sector, which hit 28 deals so far, based on search results in our Healthcare Deals Database. All but seven deals were committed by a private equity firm or its portfolio company, showing private equity’s continued influence on the Physician Medical Group market. No one particular company dominated as a buyer, but a few different firms reported multiple deals. Advanced... Read More »
Health Care M&A Deals, January 1, 2021

Health Care M&A Deals, January 1, 2021

The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is Waterland Private Equity’s acquisition of Priory Group, the U.K. behavioral healthcare operations of Acadia Healthcare Company, Inc., for $1.47 billion. The Priory Group has 361 behavioral health facilities with 8,700 beds across the U.K. Acadia Healthcare purchased Priory Group in January 2016 for $2.25 billion. In order to... Read More »
Saying Goodbye To 2020

Saying Goodbye To 2020

Note: This post was featured in our sibling publication focused on the Long-Term Care sector, The SeniorCare Investor. It’s time to put 2020 to rest, and in 2021 we will all do our best. If you happen to be listening to this on Christmas Eve Hopefully you will remember it came from Steve As you know, 2020 was a terrible year And in our industry, it brought little cheer What with shortages of tests and PPE Let’s not forget those of us who ran out of TP COVID was nasty, don’t we all know And it cost the providers a lot of dough Blame was cast by the media for sure But your resilience means we will all endure There’s no time to waste, the message still needs to get out That you are a... Read More »
Health Care M&A Deals, January 1, 2021

Health Care M&A Deals, December 25, 2020

The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is Gainwell Technologies’s acquisition of HMS for $3.4 billion. HMS provides a broad range of payment accuracy and population health management solutions, as well as analytics and engagement solutions. Gainwell Technologies, a portfolio company of Veritas Capital, is the former U.S. State and Local Health and Human Services business of DXC... Read More »
Health Care M&A Deals, January 1, 2021

Health Care M&A Deals, December 18, 2020

The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is AstraZeneca plc’s acquisition of Alexion Pharmaceuticals, Inc. for $39 billion. Alexion is a global biopharmaceutical company that has pioneered complement inhibition for a broad spectrum of immune-mediated rare diseases caused by uncontrolled activation of the complement system, a vital part of the immune system. Alexion’s expertise... Read More »
Health Care M&A Deals, January 1, 2021

Health Care M&A Deals, December 11, 2020

The Health Care M&A deals chart is a selection of transactions announced during the prior week(s). The M&A transactions presented here are from our HealthCareMandA.com Deal Database, which is updated daily to provide our subscribers with the most up-to-date information and trends in the healthcare industry. The largest deal of the week is Boehringer Ingelheim’s acquisition of NBE-Therapeutics for $1.429 billion from PPF Group. NBE-Therapeutics is a clinical-stage biotechnology company focused on antibody-drug conjugate (ADC) therapies for the treatment of solid tumors. NBE-Therapeutics’ lead compound NBE-002 is currently in Phase 1 clinical studies for triple negative breast... Read More »